ABOUT US
Press Releases
Company Profile | Leadership | Publications | Press Releases
A list of LifeSensors’ most recent press releases including product launches, collaborations, and achievements. To stay informed, please sign up to receive LifeSensors press releases here.
Date: March 7, 2012
Human SUMO-3 Patent Expands LifeSensors' Protein Expression Portfolio
LifeSensors, Inc., developer and manufacturer of SUMO-fusion technology used to overcome bottlenecks in protein production, expands its intellectual property and protein expression portfolio with its patent, “Human SUMO-3 For Enhancing Protein Expression” (US 8,119,369 B2), awarded by the United States Patent and Trademark Office last week.
Read More >>
Date: January 11, 2012
LifeSensors Announces New Director of Sales and Marketing
LifeSensors, Inc., a rapidly growing biotech company focused on developing innovative tools to facilitate protein expression and the study of the Ubiquitin Proteasome Pathway (UPP), announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director.
Download PDF >>
Date: November 29, 2011
LifeSensors Announces Bioethanol Development Collaboration with USDA, ARS SUMO Protein Production Technology Used to Enhance Baker's Yeast Enzymes & Co-Products
LifeSensors Inc., developer of SUMO-based protein expression technologies, established a Cooperative Research and Development Agreement (CRADA) with the National Center for Agricultural Utilization Research (NCAUR) of the United States Department of Agriculture – Agricultural Research Service (ARS) in Peoria, IL.
Read More >>
Date: November 28, 2011
Cayman Chemical Licenses LifeSensors' SUMO Platforms, Launches New Products
Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies.
Read More >>
Date: October 19, 2011
LifeSensors licenses SUMOpro technology to Abzyme Therapeutics
MALVERN, PA -- October 19, 2011 -- Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™.
Download PDF >>
Date: June 28, 2010
LifeSensors Launches DiUbiquitin Substrate
MALVERN, PA -- June 29, 2010 --LifeSensors, Inc., a biotechnology company, announces the launch of its novel physiologically relevant diubiquitin substrates for measuring isopeptide bond cleavage after filing for patent applications. This breakthrough technology, for both basic research and drug discovery targeting the ubiquitin proteasome pathway, offers sensitive, rapid, and robust fluorescent readouts of isopeptidase or de-ubquitylase (DUB) activity.
Read More >>
Date: September 23, 2009
LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity Ubiquitin Traps
MALVERN, Pa.--LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps.
Read More >>
Date: September 15, 2009
LifeSensors, Inc. Signs Distribution Agreement with Nacalai USA, Inc.
Nacalai USA, Inc. has entered into a distribution agreement with LifeSensors, Inc., a Malvern, Pennsylvania, based biotechnology company for distribution of LifeSensors Ubiquitin Proteasome Pathway (UPP) research tools and novel recombinant protein expression technologies in Japan, Singapore, South Korea and Taiwan.
Read More >>
Date: July 9, 2009
LifeSensors, Inc. Launches their Ubiquitin Pathway Enzymes Assay Kits Licensed from Progenra, Inc.
LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools and protein microarrays, announced today the launch of their CHOP2 Reporter assay kits for deubiquitylases (DUBs) and the imminent launch of their ubiquitin ligase assay kits.
Read More >>
